Development of integrated platform of lymphocyte phenotyping, and immunotherapy validation in single cell and 3D droplet microfluidic systems

Abstract

Immunotherapies present a promising and rapidly growing field of treatment options for cancer and other diseases. Most treatments developed by academic and industrial labs, however, will never make it to clinical use. Each year, hundreds of novel immunotherapies are in early preclinical development, while only a few more will be approved for clinical use. The scope of the